Cullinan Associates’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,074
Closed -$667K 244
2022
Q4
$667K Buy
+3,074
New +$819K 0.04% 182
2017
Q4
Sell
-1,900
Closed -$259K 187
2017
Q3
$259K Hold
1,900
0.02% 177
2017
Q2
$201K Hold
1,900
0.02% 195
2017
Q1
$201K Buy
+1,900
New +$185K 0.02% 197

Other funds holding ALB

Cullinan Associates's ALB Position: Q1 2023 in Review

Cullinan Associates sold out of Albemarle (ALB) in Q1 2023, closing a stake of 3,074 shares — an estimated $667K sold.

Cullinan Associates first reported a position in ALB in Q1 2017 and held it in 4 quarters. The position peaked at $667K in Q4 2022. 1,024 funds tracked by Wall St. Rank hold ALB as of Q1 2023.

  • Cullinan Associates reported no remaining Albemarle position as of Q1 2023 after selling out during the quarter.
  • Cullinan Associates sold 3,074 Albemarle shares in Q1 2023, an estimated $667K.
  • Cullinan Associates first reported a position in Albemarle in Q1 2017 and held it in 4 quarters.
  • Cullinan Associates's Albemarle position peaked at $667K in Q4 2022.
  • 1,024 funds tracked by Wall St. Rank held Albemarle as of Q1 2023.

Based on Cullinan Associates's 13F filing for Q1 2023, filed 5 Apr 2023.